Home • News & Events News & Events Updates about Leica Biosystems. Artificial Intelligence in Pathology: Challenges and ConsiderationsPublished: 2 August 2021 by Chad Salinas, Vice President, AI and Machine Learning Artificial Intelligence is exponentially increasing its impact on healthcare. As deep learning is mastering computer vision tasks, its application to digital pathology is natural, with the promise of aiding in routine reporting and… Leica Biosystems Achieves First In Vitro Diagnostics Regulation Certificate at Newcastle, UK Facility; Passes Audit in Amsterdam with No ObservationsPublished: 9 July 2021 Leica Biosystems is on track to align its portfolio of instrumentation and consumables with the In Vitro Diagnostics Regulation (IVDR) that comes into effect May of 2022. Internal technical and operations teams, in partnership with Quality & Regulatory Affairs, are taking steps to ensure that… Leica Biosystems Enhances Integration of Digital Pathology into the Diagnostic Pathway with DICOM ImagingPublished: 17 June 2021 VISTA, CA –June 17, 2021 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that its Next Generation Aperio GT 450 DX scanner now supports DICOM imaging. Working closely in partnership with Leeds Teaching Hospital NHS as part of the National Pathology Imaging Co-… Leica Biosystems Collaborates with European Society for Digital and Integrative Pathology (ESDIP) to Support Labs on their Way to Digital EvolutionPublished: 2 May 2021 Leica Biosystems, a global leader in pathology workflow solutions, becomes a diamond sponsor and announces the start of a collaboration with the European Society for Digital and Integrative Pathology (ESDIP) to promote digital pathology adoption across Europe. "Building bridges between industry and… Paige and Leica Biosystems Partner to Expand Access to Computational Pathology Products for Pathology and Oncology ResearchPublished: 23 April 2021 NEW YORK, NY and VISTA, CALIF. – April 23, 2021 — Paige, a global leader in AI-based digital diagnostics, and Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today announced a strategic partnership to expand access to computational pathology… Accelerate Your Discovery JourneyPublished: 22 April 2021 Imagine the possibilities for your Chromogenic Multiplex with Leica Biosystems and Cell IDx To accelerate the discovery journey in cancer research, Leica Biosystems has partnered with Cell IDx, a technology leader in multiplexed cellular immunodiagnostics, developing highly sensitive and specific… Leica Biosystems and Bio-Techne Corporation are Accelerating Disease Research with RNAscope™ COVID-19 Probes and the BOND RX*Published: 19 August 2020 Research-use-only RNA-ISH probes now available for COVID-19 on our automated platform Leica Biosystems, in partnership with Bio-Techne Corporation, announces the automation of RNAscope™ COVID-19 probes’ on BOND RX*, its staining platform, for research use only. Researchers now have the capability… Leica Biosystems Unveils its Aperio GT 450 DX Digital Pathology Scanner and Delivers Excellence to Leeds Teaching Hospitals NHS Trust, UKPublished: 11 August 2020 Leica Biosystems, a global leader in pathology workflow solutions, announced the European launch of its Aperio GT 450 DX digital pathology scanner. This next generation imaging system was unveiled at the highly successful Leica Biosystems Digital Pathology Virtual Summit and is already installed at… FDA Expands Leica Biosystems Enforcement Discretion Enabling Remote Diagnosis Using Aperio Webviewer and Aperio AT2 Scanners During Covid-19 CrisisPublished: 24 April 2020 VISTA, CA April 24, 2020 – Leica Biosystems, the global leader in pathology workflow solutions, today announced it has received additional notification from the U.S. Food & Drug Administration (FDA) about its intention to exercise enforcement discretion when the Aperio WebViewer, a web-based… Leica Biosystems Receives FDA’s Enforcement Discretion for Use of Aperio ImageScope DX Viewing Software for Remote Diagnosis During COVID-19 EmergencyPublished: 3 April 2020 VISTA, CA, April 3, 2020 – Leica Biosystems, the global leader in pathology workflow solutions, today announced it has received notification from the U.S. Food & Drug Administration ( FDA ) that its Aperio ImageScope DX Viewer with images acquired on the Aperio AT2 DX Scanner can be used for… Pagination « Previous Page 1 Page 2 Current page 3 Page 4 » Next
